PBMC
Showing 51 - 75 of 1,674
Immune Response in Patients With Hepatitis B and C Infection
Recruiting
- Hepatitis B
- Hepatitis C
-
Basildon, Essex, United KingdomBasildon Hospital
Apr 5, 2022
Responsiveness in Oncology Patients Based on Host Response
Recruiting
- Non Small Cell Lung Cancer
- Healthy
- blood, stool and tissue samples collection
-
Dallas, TexasBaylor Scott and White Research Institute
Feb 9, 2023
T-Cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (CD5 CAR T (CT125B))
Recruiting
- T-Cell Acute Lymphoblastic Leukemia/Lymphoma
- CD5 CAR T (CT125B)
-
Beijing, Beijing, ChinaBeijing Gaobo Boren Hospital
Aug 3, 2022
Vaccine Response Impaired Trial in Adelaide (BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule)
Recruiting
- Vaccine Response Impaired
- BCG vaccine
- +3 more
-
Adelaide, South Australia, AustraliaSouth Australian Health and Medical Research Institute
Nov 17, 2023
Diabetic Kidney Disease, Diabetes Type 2, Chronic Kidney Diseases Trial
Not yet recruiting
- Diabetic Kidney Disease
- +3 more
- (no location specified)
Nov 23, 2022
Nutrition, Healthy Trial (fish oil)
Not yet recruiting
- Nutrition, Healthy
- fish oil
- (no location specified)
Aug 12, 2022
Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis Trial in Chicago (CNP-106, Placebo)
Not yet recruiting
- Myasthenia Gravis
- +3 more
- CNP-106
- Placebo
-
Chicago, IllinoisResearch Site
Oct 30, 2023
Rosuvastatin and Evolocumab for Coronary Artery Disease
Completed
- Coronary Artery Disease
-
New York, New YorkMount Sinai Hospital
Aug 2, 2023
MDD, Overweight, Inflammation Trial in Atlanta, Boston (Placebo, EPA 1 g/day, EPA 2 g/day)
Completed
- Major Depressive Disorder
- +2 more
- Placebo
- +3 more
-
Atlanta, Georgia
- +1 more
Apr 4, 2022
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
- Melanoma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 6, 2023
FPP, Fermented Papaya Preparation, Supplements Trial in Indianapolis (Supplement)
Recruiting
- FPP
- +4 more
- Supplement
-
Indianapolis, IndianaIndiana University Health Methodist Hospital
Feb 22, 2022
CKD (Chronic Kidney Disease) Stage 5D Trial (Sodium propionate, Placebo)
Not yet recruiting
- CKD (Chronic Kidney Disease) Stage 5D
- Sodium propionate
- Placebo
- (no location specified)
May 4, 2023
Drug Interaction Trial in Bangkok (Estradiol valerate 2 mg, cyproterone acetate 25 mg)
Active, not recruiting
- Drug Interaction
- Estradiol valerate 2 mg, cyproterone acetate 25 mg
-
Bangkok, Pathumwan, ThailandInstitute of HIV Research and Innovation (IHRI)
Oct 19, 2022
Glaucoma, Open-Angle Trial in United Kingdom (Nicotinomide, Matching )
Not yet recruiting
- Glaucoma, Open-Angle
- Nicotinomide
- Matching placebo
-
Belfast, Northern Ireland, United Kingdom
- +6 more
Nov 15, 2022
Advanced Solid Tumors Trial in Chongqing (TC-N201 cells, IL-2, Fludarabine)
Recruiting
- Advanced Solid Tumors
- TC-N201 cells
- +4 more
-
Chongqing, ChinaTCRCure Biopharma Ltd.
May 25, 2023
Collection of Blood From Patients With Cancer
Recruiting
- Prostate Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Systemic Lupus Erythematosus Trial in Vandoeuvre les nancy
Not yet recruiting
- Systemic Lupus Erythematosus
-
Vandoeuvre les nancy, Lorraine, FranceThomas Moulinet
Jun 15, 2022
Acute Myeloid Leukemia Trial in Beijing (Dual CD33/CLL1 CAR T)
Recruiting
- Acute Myeloid Leukemia
- Dual CD33/CLL1 CAR T
-
Beijing, Beijing, ChinaBeijing Boren Hospital
Feb 16, 2022
Implication of 5-HT7 Receptor in Inflammatory Mechanisms in
Not yet recruiting
- Healthy
- Multiple Sclerosis
- Blood sample
-
Orléans, FranceCHR Orléans
Feb 16, 2023
Parkinson's Disease Trial in Novara (Probiotics, Placebo)
Enrolling by invitation
- Parkinson's Disease
- Probiotics
- Placebo
-
Novara, ItalyAzienda Ospedaliero-Universitaria "Maggiore della Carità"
Jun 9, 2022
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022
Antibody-mediated Rejection, Kidney Tranplant Trial in Hangzhou (Daratumumab)
Not yet recruiting
- Antibody-mediated Rejection
- Kidney Tranplant
-
Hangzhou, Zhejiang, China79# Qingchun Road
Jun 21, 2023
System for Early Warning and Prognostic Evaluation of Sepsis
Recruiting
- Sepsis
- +4 more
- Peripheral blood test
-
Xi'an, Shannxi, ChinaThe First Affillated Hospital,the Air Force Medical University
Jan 28, 2023
The Immu-KNEE-ty Study
Not yet recruiting
- Immunosenescence
- Aging
- Knee arthroplasty
-
Ede, NetherlandsGelderse Vallei Hospital
Jun 15, 2023
Vascular Function, Healthy, Diabetes Trial (Soup)
Not yet recruiting
- Vascular Function
- +2 more
- Soup
- (no location specified)
Jul 28, 2023